
Release date: 2024-08-20 16:40:55 Article From: Lucius Laos Recommended: 287
Launched in Japan in 2021, anamoline is the world's first drug specifically for the treatment of cachexia; As a ghrelin receptor agonist, it is able to increase the patient's appetite, increase body weight and muscle mass. The advent of anamoline fills a gap in the field of cancer cachexia therapy.
Anamorelin is specifically used to relieve symptoms of cancer cachexia, especially weight loss and decreased appetite caused by cancer.
It is indicated for the treatment of colorectal cancer patients, especially in support of disease-related cachexia and weight loss.
For those with cancer cachexia who do not respond well to standard nutritional therapy, anamarin can be used as a complementary treatment to help improve weight and appetite.
With effective treatment for these symptoms, anamoline helps to improve the patient's quality of life and overall well-being. It is important to understand the precautions associated with medication before using the drug.
When using anamoline, the following things can help optimize treatment outcomes and reduce potential risks.
In patients with underlying heart conditions, such as valvular disease and cardiomyopathy, anamarin may suppress heart function and worsen symptoms.
These patients may have cardiac dysfunction and symptoms may worsen.
Adhering to these precautions can help you better manage your treatment and improve its outcomes. Next, we will explore the interaction of anamarin with other drugs.
Understanding drug interactions is essential to optimize treatment and avoid potential risks. Next, we will detail the interactions that anamarin may have with other medications.
Drugs like piperacillin and hydrochloride chloride also have sodium channel inhibition, and their use in combination with Anamorelin may increase the risk of arrhythmias, requiring special attention to changes in cardiac symptoms.
Drugs such as atenolol can have a suppressive effect on cardiac function, and when used with anamolin, it may exacerbate the side effects of cardiac function suppression, and cardiac function should be closely monitored.
Having this information on drug interactions can help patients better manage their treatment and avoid unnecessary risks.
[Warm tips] Please pay attention to the compatibility with other drugs during the use of anamoline, and adjust the medication regimen in time if there is any change or discomfort.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:2622025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:4832024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended:2672025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended:2772025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended:2582025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended:3032025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended:2652025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended:2442025-27-11

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: